Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Rexulti (brexpiprazole)
pCPA File Number:
21025
Negotiation Status:
Concluded with an LOI
Indication(s):
Schizophrenia
Sponsor/Manufacturer:
Otsuka Canada Pharmaceuticals
CADTH Project Number:
SR0514-000
pCPA Engagement Letter Issued:
2018-04-04
Negotiation Process Concluded:
2018-12-14